Delia Brambila has begun serving a one-year sentence at the Maguire Correctional Facility after resolving a San Mateo County case involving identity theft and forged prescriptions. The 59-year-old San Mateo resident pleaded no contest to two identity-theft charges and two prescription-forgery charges, according to KRON4, which cited the District Attorney’s Office and court records.
The sentence also includes two years and four months of mandatory supervision after her release. Brambila began the jail term Monday and had remained out of custody during the court proceedings, KRON4 reported.
A sharply reduced case
The no-contest plea resolved four charges out of an original 61 felony counts. Under the negotiated disposition, prosecutors dismissed 57 counts: 28 additional identity-theft counts, 26 counts involving forged prescriptions, two grand-theft counts and one employee-embezzlement count, according to the reported court disposition.
That agreement defines the criminal case’s outcome, but it does not establish the allegations attached to the dismissed counts. The charges resolved by the plea were two counts of identity theft and two counts of prescription forgery; the available reporting does not provide a separate finding on each dismissed allegation.
What prosecutors alleged
Prosecutors said Brambila’s access came through 15 years of work as a medical assistant for a Portola Valley physician. They alleged that, from 2017 through 2023, she used financial information belonging to the doctor and patients to make unauthorized purchases. They also alleged that prescriptions connected to fictitious patients were used to obtain medication delivered to her home, according to KRON4.
The investigation reportedly began after a patient discovered that their credit-card number had been used for unauthorized purchases. The available account does not identify the medications involved, say whether they were controlled substances, or describe any finding that a particular prescribing or dispensing system failed.
What California’s prescription safeguards do—and do not—show here
California’s CURES database tracks prescriptions for Schedule II through V controlled substances dispensed in the state and is intended to support public-health, regulatory and law-enforcement work, according to the California Department of Justice. Access is restricted: practitioners and pharmacists may view information only for patients under their care, while regulators and law-enforcement officials may use it for agency purposes involving diversion and abuse.
Separately, the Medical Board of California says controlled-substance prescriptions must comply with specified federal regulations, including requirements governing electronic prescriptions. Those rules provide the regulatory backdrop for prescription handling, but the available reporting does not say that CURES, electronic-prescription requirements or a Medical Board investigation played a role in Brambila’s case.
The documented result is therefore narrower than the original charging total: Brambila is serving the negotiated jail term after her no-contest plea, while the broader allegations were dismissed under the agreement. Further details about the medications, the prescriptions’ status under California’s controlled-substance rules and any role played by medical or pharmacy oversight systems remain unspecified in the available records.
